These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21933803)

  • 1. Baseline delayed left ventricular activation predicts long-term clinical outcome in cardiac resynchronization therapy recipients.
    Eitel C; Wilton SB; Switzer N; Cowan K; Exner DV
    Europace; 2012 Mar; 14(3):358-64. PubMed ID: 21933803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality and morbidity in cardiac resynchronization patients: impact of lead position, paced left ventricular QRS morphology and other characteristics on long-term outcome.
    Jastrzebski M; Wilinski J; Fijorek K; Sondej T; Czarnecka D
    Europace; 2013 Feb; 15(2):258-65. PubMed ID: 23047489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paced left ventricular QRS width and ECG parameters predict outcomes after cardiac resynchronization therapy: PROSPECT-ECG substudy.
    Hsing JM; Selzman KA; Leclercq C; Pires LA; McLaughlin MG; McRae SE; Peterson BJ; Zimetbaum PJ
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):851-7. PubMed ID: 21956038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanical dyssynchrony evaluated by tissue Doppler cross-correlation analysis is associated with long-term survival in patients after cardiac resynchronization therapy.
    Risum N; Williams ES; Khouri MG; Jackson KP; Olsen NT; Jons C; Storm KS; Velazquez EJ; Kisslo J; Bruun NE; Sogaard P
    Eur Heart J; 2013 Jan; 34(1):48-56. PubMed ID: 22390911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial.
    Thébault C; Donal E; Meunier C; Gervais R; Gerritse B; Gold MR; Abraham WT; Linde C; Daubert JC;
    Eur Heart J; 2012 Nov; 33(21):2662-71. PubMed ID: 22285578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of response to cardiac resynchronization therapy in patients with a non-left bundle branch block morphology.
    Rickard J; Bassiouny M; Cronin EM; Martin DO; Varma N; Niebauer MJ; Tchou PJ; Tang WH; Wilkoff BL
    Am J Cardiol; 2011 Dec; 108(11):1576-80. PubMed ID: 21890086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular conduction delays and relation to QRS configuration in patients with left ventricular dysfunction.
    Varma N
    Am J Cardiol; 2009 Jun; 103(11):1578-85. PubMed ID: 19463519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.
    Pouleur AC; Knappe D; Shah AM; Uno H; Bourgoun M; Foster E; McNitt S; Hall WJ; Zareba W; Goldenberg I; Moss AJ; Pfeffer MA; Solomon SD;
    Eur Heart J; 2011 Jul; 32(14):1720-9. PubMed ID: 21609974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting hyperresponse among pacemaker-dependent nonischemic cardiomyopathy patients upgraded to cardiac resynchronization.
    Adelstein E; Schwartzman D; Gorcsan J; Saba S
    J Cardiovasc Electrophysiol; 2011 Aug; 22(8):905-11. PubMed ID: 21332868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.
    Brignole M; Botto G; Mont L; Iacopino S; De Marchi G; Oddone D; Luzi M; Tolosana JM; Navazio A; Menozzi C
    Eur Heart J; 2011 Oct; 32(19):2420-9. PubMed ID: 21606084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged paced QRS duration as a predictor for congestive heart failure in patients with right ventricular apical pacing.
    Miyoshi F; Kobayashi Y; Itou H; Onuki T; Matsuyama T; Watanabe N; Liu C; Kawamura M; Asano T; Miyata A; Nakagawa H; Tanno K; Baba T; Katagiri T
    Pacing Clin Electrophysiol; 2005 Nov; 28(11):1182-8. PubMed ID: 16359284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular conduction delays induced by right ventricular apical pacing: effect of left ventricular dysfunction and bundle branch block.
    Varma N
    J Cardiovasc Electrophysiol; 2008 Feb; 19(2):114-22. PubMed ID: 17971145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure.
    Foley PW; Muhyaldeen SA; Chalil S; Smith RE; Sanderson JE; Leyva F
    Europace; 2009 Apr; 11(4):495-501. PubMed ID: 19307283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of electrocardiographic measurements before and after cardiac resynchronization device implantation in patients with heart failure due to ischemic or nonischemic cardiomyopathy.
    Iler MA; Hu T; Ayyagari S; Callahan TD; Civello KC; Thal SG; Wilkoff BL; Chung MK
    Am J Cardiol; 2008 Feb; 101(3):359-63. PubMed ID: 18237600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.
    Boriani G; Gasparini M; Landolina M; Lunati M; Proclemer A; Lonardi G; Iacopino S; Rahue W; Biffi M; DiStefano P; Grammatico A; Santini M;
    Eur J Heart Fail; 2011 Aug; 13(8):868-76. PubMed ID: 21558331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underestimation of duration of ventricular activation by 12-lead ECG compared with direct measurement of activation duration derived from implanted pacemaker leads.
    Duncan AM; Lim E; Mebrate Y; Wong T; Gibson DG
    Int J Cardiol; 2011 Oct; 152(1):35-42. PubMed ID: 20678820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of right ventricular peak systolic pressure to major adverse events in patients undergoing cardiac resynchronization therapy.
    Tedrow UB; Kramer DB; Stevenson LW; Stevenson WG; Baughman KL; Epstein LM; Lewis EF
    Am J Cardiol; 2006 Jun; 97(12):1737-40. PubMed ID: 16765124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar long-term benefits conferred by apical versus mid-septal implantation of the right ventricular lead in recipients of cardiac resynchronization therapy systems.
    Bulava A; Lukl J
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S32-7. PubMed ID: 19250108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
    Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
    Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.